Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
role decrease » fold decrease (Expand Search), rate decreased (Expand Search), road decreased (Expand Search)
increase » increased (Expand Search)
Showing 1,881 - 1,900 results of 23,096 for search '(( significant ((role decrease) OR (fold increase)) ) OR ( significant decrease decrease ))', query time: 0.63s Refine Results
  1. 1881
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1882
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1883
    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability

    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability by You Zou (2601964)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 1884
    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability

    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability by You Zou (2601964)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 1885
    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability

    Top-Down Stability of Proteins from Rates of Oxidation (TD-SPROX) Approach for Measuring Proteoform-Specific Folding Stability by You Zou (2601964)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 1886
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  7. 1887
    Effects of BM-MSCs on ROS generation in DCS rats.

    Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1888
    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation.

    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1889
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 1890
    Characterization of BM-MSC.

    Characterization of BM-MSC. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1891
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1892
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1893
    The ANCOVA and Post_hoc results.

    The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1894
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1895
    Identification of BM-MSCs.

    Identification of BM-MSCs. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1896
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1897
    Effect of BM-MSCs in improving DCS induced lung injury.

    Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1898
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1899
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1900
    Time to stabilization in the mediolateral direction.

    Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: